Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sutro Biopharma (STRO) Preferred Shares Issued (2018)

Historic Preferred Shares Issued for Sutro Biopharma (STRO) over the last 1 years, with Q3 2018 value amounting to $51.5 million.

  • Sutro Biopharma's Preferred Shares Issued changed N/A to $51.5 million in Q3 2018 from the same period last year, while for Sep 2019 it was $51.5 million, marking a year-over-year change of. This contributed to the annual value of $84.7 million for FY2018, which is N/A changed from last year.
  • Per Sutro Biopharma's latest filing, its Preferred Shares Issued stood at $51.5 million for Q3 2018.
  • Sutro Biopharma's 5-year Preferred Shares Issued high stood at $51.5 million for Q3 2018, and its period low was $51.5 million during Q3 2018.